ChemicalBook > CAS DataBase List > Navivumab
Navivumab
- Product Name
- Navivumab
- CAS No.
- 1443004-16-7
- Chemical Name
- Navivumab
- Synonyms
- Navivumab;Navivumab (anti-HA);Research Grade Navivumab;Research Grade Navivumab (DVV03803)
- CBNumber
- CB08080938
- Formula Weight
- 0
- MOL File
- Mol file
More
Less
Navivumab Property
- form
- Liquid
- color
- Colorless to light yellow
More
Less
Navivumab Chemical Properties,Usage,Production
Uses
Navivumab (CT-P23) is an influenza A virus hemagglutinin HA monoclonal antibody. neutralizes H1, H2, H5, and H9 influenza A viruses by binding to the stem fusion domain in HA2[1].
References
[1] Beigel JH. Polyclonal and monoclonal antibodies for the treatment of influenza. Curr Opin Infect Dis. 2018 Dec;31(6):527-534. DOI:10.1097/QCO.0000000000000499
Navivumab Preparation Products And Raw materials
Raw materials
Preparation Products
More
Less
Navivumab Suppliers
- Tel
- 021-61312847; 18021002903
- Fax
- QQ:3008007432
- 3008007409@qq.com
- Country
- China
- ProdList
- 71826
- Advantage
- 60
- Tel
- 177-54423994 17754423994
- Fax
- QQ:2853530913
- 2853530910@QQ.com
- Country
- China
- ProdList
- 8000
- Advantage
- 62
- Tel
- 15817493340
- 981810490@qq.com
- Country
- China
- ProdList
- 1566
- Advantage
- 58
- Tel
- 027-65317797 15926423062
- Fax
- QQ:422450190
- 422450190@qq.com
- Country
- China
- ProdList
- 10308
- Advantage
- 58
- Tel
- 65279366 18108604356
- products@biolabreagent.com
- Country
- China
- ProdList
- 9868
- Advantage
- 58
- Tel
- 13720134139 086-15871494362 13720134139
- orders@jknbiochem.com
- Country
- China
- ProdList
- 6972
- Advantage
- 58
- Tel
- 021-65675885 18964387627
- customer_service@efebio.com
- Country
- China
- ProdList
- 11973
- Advantage
- 58
- Tel
- 15111215862 15111215862
- 3062105966@qq.com
- Country
- China
- ProdList
- 4202
- Advantage
- 58
- Tel
- 17316404525 17316404525
- 209533805@qq.com
- Country
- China
- ProdList
- 9792
- Advantage
- 58
- Tel
- 0573-83568680 18057391398
- 3956524501@qq.com
- Country
- China
- ProdList
- 1442
- Advantage
- 58
1443004-16-7, NavivumabRelated Search:
Rosmantuzumab
Cendakimab
Gresonitamab
Anrukinzumab
Tibulizumab
Lusvertikimab
Talacotuzumab
Ivicentamab
Flanvotumab
Firivumab